40844 Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 

respond to requests for consultation, 

and to support the site-specific response 

actions conducted by ATSDR, as 

otherwise necessary. 

DATES: Nominations from the Substance 

Priority List and/or additional 

substances must be received by August 

30, 2021. 

ADDRESSES: You may submit 

nominations, identified by Docket No. 

ATSDR–2021–0006 by any of the 

following methods: 

• Internet: Access the Federal 

eRulemaking portal at 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Office of Innovation and 

Analytics, Agency for Toxic Substances 

and Disease Registry, 1600 Clifton Rd. 

NE, Mail Stop S102–1, Atlanta, GA 

30329–4027. Attn: Docket No. ATSDR– 

2021–0006. 

Instructions: All submissions must 

include the agency name and docket 

number for this notice. All relevant 

comments will be posted without 

change. This means that no confidential 

business information or other 

confidential information should be 

submitted in response to this notice. 

Refer to the section Submission of 

Nominations (below) for the specific 

information required. 

FOR FURTHER INFORMATION CONTACT: For 

further information, please contact 

Kambria Haire, Agency for Toxic 

Substances and Disease Registry, Office 

of Innovation and Analytics, 1600 

Clifton Rd. NE, Mail Stop S102–1, 

Atlanta, GA 30329–4027, Email: 

ATSDRToxProfileFRNs@cdc.gov; Phone: 

1–800–232–4636. 

SUPPLEMENTARY INFORMATION: The 

Superfund Amendments and 

Reauthorization Act of 1986 (SARA) [42 

U.S.C. 9601 et seq.] amended the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA or Superfund) [42 

U.S.C. 9601 et seq.] by establishing 

certain requirements for ATSDR and the 

U.S. Environmental Protection Agency 

(EPA) with regard to hazardous 

substances most commonly found at 

facilities on the CERCLA National 

Priorities List (NPL) (for more 

information, visit www.epa.gov/ 

superfund/superfund-nationalpriorities-list-npl. Among these statutory 

requirements is a mandate for the 

Administrator of ATSDR to prepare 

Toxicological Profiles for each 

substance included on the Substance 

Priority List. This list identifies 275 

hazardous substances found at NPL sites 

that ATSDR and EPA have determined 

pose the most significant current 

potential threat to human health. 

Substances to be evaluated for 

Toxicological Profile development: Each 

year, ATSDR develops a list of 

substances to be considered for 

Toxicological Profile development. The 

nomination process includes 

consideration of all substances on 

ATSDR’s SPL, as well as other 

substances nominated by the public. For 

more information on ATSDR’s SPL, visit 

www.atsdr.cdc.gov/SPL/. 

Submission of nominations for 

Toxicological Profile development: This 

notice invites voluntary public 

nominations for substances included on 

the SPL and for substances not listed on 

the SPL. When nominating a non-SPL 

substance, please include the rationale 

for the nomination. ATSDR will 

evaluate data and information 

associated with nominated substances 

and will determine the final list of 

substances to be chosen for 

Toxicological Profile development. 

Substances will be chosen according to 

ATSDR’s specific guidelines for 

selection. These guidelines can be found 

in the Selection Criteria, which may be 

accessed at www.atsdr.cdc.gov/ 

toxprofiles/guidance/ATSDR_TP_

Selection%20Criteria.pdf. 

Donata Green, 

Acting Director, Office of Policy, Partnerships 

and Planning, Agency for Toxic Substances 

and Disease Registry. 

[FR Doc. 2021–16195 Filed 7–28–21; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[Docket No. ATSDR–2021–0005] 

Availability of Six Draft Toxicological 

Profiles 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Agency for Toxic 

Substances and Disease Registry 

(ATSDR), within the Department of 

Health and Human Services (HHS), 

announces the opening of a docket to 

obtain comments on drafts of six 

updated Toxicological Profiles: Acetone, 

Aldrin/Dieldrin, Chlorophenols, 3,3- 

Dichlorobenzidine, Disulfoton, and 

Pentachlorophenol. 

DATES: Written comments must be 

received on or before October 27, 2021. 

ADDRESSES: You may submit comments, 

identified by docket number ATSDR– 

2021–0005, by any of the following 

methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Office of Innovation and 

Analytics, Agency for Toxic Substances 

and Disease Registry, 1600 Clifton Rd. 

NE, Mail Stop S102–1, Atlanta, GA, 

30329–4027. Attn: Docket No. ATSDR– 

2021–0005. 

Instructions: All submissions must 

include the agency name and Docket 

Number. All relevant comments 

received will be posted without change 

to http://regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

http://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Kambria Haire, Agency for Toxic 

Substances and Disease Registry, Office 

of Innovation and Analytics, 1600 

Clifton Rd. NE, Mail Stop S102–1, 

Atlanta, GA, 30329–4027, Email: 

ATSDRToxProfileFRNs@cdc.gov; Phone: 

1–800–232–4636. 

SUPPLEMENTARY INFORMATION: ATSDR 

has prepared drafts of six updated 

toxicological profiles based on 

availability of new health effects and 

other information since their initial 

release. All toxicological profiles issued 

as ‘‘Drafts for Public Comment’’ 

represent the result of ATSDR’s 

evidence-based evaluations to provide 

important toxicological information on 

priority hazardous substances. ATSDR 

is seeking public comments and 

additional information or reports on 

studies about the health effects of these 

six substances for review and potential 

inclusion in the profiles. ATSDR 

considers key studies for these 

substances during the profile 

development process. This notice 

solicits any relevant, additional studies. 

ATSDR will evaluate the quality and 

relevance of such data or studies for 

possible inclusion in the profile. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, information, and data. 

Please note that comments received, 

including attachments and other 

supporting materials, are part of the 

public record and are subject to public 

disclosure. Comments will be posted on 

https://www.regulations.gov. Therefore, 

do not include any information in your 

comment or supporting materials that 

you consider confidential or 

inappropriate for public disclosure. If 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 40845 

you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be on 

public display. ATSDR will review all 

submissions and may choose to redact, 

or withhold, submissions containing 

private or proprietary information such 

as Social Security numbers, medical 

information, inappropriate language, or 

duplicate/near duplicate examples of a 

mass-mail campaign. ATSDR will 

carefully consider all comments 

submitted in preparation of the final 

Toxicological Profiles and may revise 

the profiles as appropriate. 

Legislative Background 

The Superfund Amendments and 

Reauthorization Act of 1986 (SARA) [42 

U.S.C. 9601 et seq.] amended the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA or Superfund) [42 

U.S.C. 9601 et seq.] by establishing 

certain requirements for ATSDR and the 

U.S. Environmental Protection Agency 

(EPA) regarding the hazardous 

substances most commonly found at 

facilities on the CERCLA National 

Priorities List (NPL). Among these 

statutory requirements is a mandate for 

the Administrator of ATSDR to prepare 

toxicological profiles for each substance 

included on the priority list of 

hazardous substances [also called the 

Substance Priority List (SPL)]. This list 

identifies 275 hazardous substances that 

ATSDR and EPA have determined pose 

the most significant potential threat to 

human health. The SPL is available 

online at www.atsdr.cdc.gov/spl. 

ATSDR is also mandated to revise and 

publish updated toxicological profiles, 

as necessary, to reflect updated health 

effects and other information. 

In addition, CERCLA provides ATSDR 

with the authority to prepare 

toxicological profiles for substances not 

found on the SPL. CERCLA authorizes 

ATSDR to establish and maintain an 

inventory of literature, research, and 

studies on the health effects of toxic 

substances (CERCLA Section 

104(i)(1)(B); 42 U.S.C. 9604(i)(1)(B)); to 

respond to requests for health 

consultations (CERCLA Section 

104(i)(4); 42 U.S.C. 9604(i)(4)); and to 

support the site-specific response 

actions conducted by the agency. Public 

nominations for substances from the 

SPL (or other substances)for 

toxicological profile development were 

requested on April 18, 2018 

(83FR17177–17178). 

ATSDR has now prepared drafts of six 

updated toxicological profiles based on 

availability of new health effects and 

other information since their initial 

release. 

Availability 

The Draft Toxicological Profiles are 

available online at http://

www.atsdr.cdc.gov/ToxProfiles and at 

www.regulations.gov, Docket No. 

ATSDR–2021–0005. 

Donata Green, 

Acting Director, Office of Policy, Planning 

and Partnerships, Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2021–16188 Filed 7–28–21; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10545 and CMS– 

R–185] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by August 30, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain.. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at: https://

www.cms.gov/Regulations-andGuidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Outcome and 

Assessment Information Set (OASIS) 

OASIS–D; Use: Due to the COVID–19 

related Public Health Emergency, the 

next version of the Outcome and 

Assessment Information Set (OASIS), 

version E planned for implementation 

January 1, 2021, was delayed. This 

request is for the Office of Management 

and Budget (OMB) approval to extend 

the current OASIS–D expiration date in 

order for home health agencies to 

continue data collection required for 

participation in the Medicare program. 

The current version of the OASIS–D, 

data item set was approved by OMB on 

December 6, 2018 and implemented on 

January 1, 2019. This request includes 

updated calculations using 2020 data for 


jbell on DSKJLSW7X2PROD with NOTICES